000 01206 a2200313 4500
005 20250515233741.0
264 0 _c20101021
008 201010s 0 0 jpn d
022 _a0917-5857
024 7 _aCliCa100812451252
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTanaka, Hiroyuki
245 0 0 _a[Genetic basis for skeletal disease. Osteogenesis imperfecta].
_h[electronic resource]
260 _bClinical calcium
_cAug 2010
300 _a1245-52 p.
_bdigital
500 _aPublication Type: English Abstract; Journal Article; Review
650 0 4 _aBone Density Conservation Agents
_xadministration & dosage
650 0 4 _aDiphosphonates
_xadministration & dosage
650 0 4 _aEvidence-Based Dentistry
650 0 4 _aFractures, Bone
_xetiology
650 0 4 _aHuman Growth Hormone
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aInfusions, Intravenous
650 0 4 _aOsteogenesis Imperfecta
_xdrug therapy
650 0 4 _aParathyroid Hormone
_xadministration & dosage
650 0 4 _aRandomized Controlled Trials as Topic
773 0 _tClinical calcium
_gvol. 20
_gno. 8
_gp. 1245-52
856 4 0 _uhttps://doi.org/CliCa100812451252
_zAvailable from publisher's website
999 _c20015249
_d20015249